Considering all of these inquiries and our experiment results, further experimental validation is urgently needed to carefully uncover the interactions between Siglec9 and these identified proteins and figure out their biological consequences in the bladder cancer microenvironment. This evidence concerns the gene SIGLEC9 and urinary bladder carcinoma.